Current Report Filing (8-k)
October 18 2016 - 7:10AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
_______________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 14, 2016
SPECTRUM PHARMACEUTICALS, INC.
(Exact name of registrant as specified in its charter)
|
|
|
|
Delaware
|
001-35006
|
93-0979187
|
(State or Other Jurisdiction
of Incorporation)
|
(Commission
File Number)
|
(IRS Employer
Identification No.)
|
|
|
|
|
|
11500 S. Eastern Ave., Ste. 240, Henderson, NV
|
89052
|
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
Registrant's telephone number, including area code:
(702) 835-6300
Not Applicable
(Former name or former address if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
On October 14, 2016, Luigi Lenaz, MD was appointed as Lead Director of Spectrum Pharmaceuticals, Inc. A press release dated October 18, 2016 announcing this appointment is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
|
|
|
|
Exhibit No.
|
|
Description
|
99.1
|
|
Press Release dated October 18, 2016
|
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
Spectrum Pharmaceuticals, Inc.
|
|
|
|
Date: October 18, 2016
|
By:
|
/s/ Kurt A. Gustafson
|
|
|
Kurt A. Gustafson
|
|
|
Executive Vice President and Chief
|
|
|
Financial Officer
|
EXHIBIT INDEX
|
|
|
|
Exhibit No.
|
|
Description
|
99.1
|
|
Press Release dated October 18, 2016.
|
Spectrum Pharmaceuticals (NASDAQ:SPPI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Spectrum Pharmaceuticals (NASDAQ:SPPI)
Historical Stock Chart
From Sep 2023 to Sep 2024